COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results

Go back to COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
(NASDAQ: CSCI) Delayed: 2.72 --0 (-0%)
Previous Close $2.72    52 Week High
Open $2.72    52 Week Low
Day High $2.72    P/E N/A 
Day Low $2.72    EPS
Volume 112